AIH:NSD-Aesthetic Medical International Holdings Group Limited (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 5.42

Change

-0.09 (-1.63)%

Market Cap

USD 0.14B

Volume

0.08M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 25 treatment centers in China, Hong Kong, and Singapore. The company was founded in 1997 and is headquartered in Shenzhen, China.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-16 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys, Inc

-1.03 (-0.36%)

USD9.33B 51.45 32.87
LHCG LHC Group, Inc

+2.39 (+1.19%)

USD6.25B 56.50 25.91
ACHC Acadia Healthcare Company, Inc

+1.84 (+3.05%)

USD5.22B 47.80 18.63
ENSG The Ensign Group, Inc

-1.24 (-1.33%)

USD5.10B 30.49 21.22
SGRY Surgery Partners, Inc

+0.13 (+0.30%)

USD2.65B 63.00 20.21
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
HCSG Healthcare Services Group, Inc

+0.19 (+0.66%)

USD2.15B 21.82 12.96
ADUS Addus HomeCare Corporation

-0.11 (-0.10%)

USD1.70B 51.63 31.12
PNTG The Pennant Group, Inc

-0.66 (-1.54%)

USD1.23B 188.80 65.57
AMEH Apollo Medical Holdings, Inc

-0.09 (-0.33%)

USD1.20B 26.86 5.76

ETFs Containing AIH

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.85% 44% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.85% 44% F 41% F
Trailing 12 Months  
Capital Gain -37.99% 11% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -37.99% 11% F 4% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.04% 22% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.04% 17% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 11.92% 100% A+ 88% B+
Risk Adjusted Return -59.07% 6% F 5% F
Market Capitalization 0.14B 26% F 26% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.68 100% A+ 78% C+
Price/Book Ratio 2.54 89% B+ 58% F
Price / Cash Flow Ratio 1.65 68% D+ 56% F
EV/EBITDA 2.85 100% A+ 90% A-
Management Effectiveness  
Return on Equity -90.16% 21% F 13% F
Return on Invested Capital -5.12% 32% F 37% F
Return on Assets -12.04% 32% F 27% F
Debt to Equity Ratio 2.36% 94% A 85% B
Technical Ratios  
Short Ratio 0.24 94% A 87% B+
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.